MassIVE MSV000088088

Partial Public

Simultaneously Identifying and Distinguishing Glycoproteins with O-GlcNAc and the Tn Antigen in Human Cancer Cells

Description

Proteins modified with O-GlcNAc and O-GalNAc (the Tn antigen) play critically important roles in many physiological and pathological processes. Comprehensive and site-specific analysis of proteins modified with O-GlcNAc and the Tn antigen advances our understanding of glycoprotein functions and cellular activities. However, it is extraordinarily challenging to distinguish them because of the same chemical composition (identical molecular weights) and being localized on the same amino acid residues (S/T). Here, an effective method is developed through the integration of metabolic labeling, chemical and enzymatic reactions, and MS-based proteomics to simultaneously identify and distinguish glycoproteins modified with O-GlcNAc and the Tn antigen. In biologically duplicate experiments, 537 O-GlcNAcylated proteins and 103 glycoproteins modified with the Tn antigen were identified site-specifically in human cancer cells. Among O-GlcNAcylated proteins only in Jurkat cells, those involved in HTLV-1 infection were highly enriched, indicating that O-GlcNAcylation may play a role in regulating cellular response to the retrovirus. Glycoproteins in the spliceosome and with the nuclear localization signal (NLS) are also overrepresented. However, the O-GlcNAcylated proteins identified in all three cell lines were highly enriched with transcription and RNA binding functions. For glycoproteins with the Tn antigen, while many of them in Jurkat cells were highly enriched in the extracellular exosome, those in MCF7 and K562 cells were extensively found in the ER. The current method enables us to simultaneously analyze and unambiguously distinguish glycoproteins with O-GlcNAc and the Tn antigen, and it can be extensively applied for glycoscience research. [doi:10.25345/C5FG0C] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Glycoproteins, O-GlcNAcylation and O-GalNAcylation, Proteomics, Mass spectrometry, Simultaneous identification and distinction

Contact

Principal Investigators:
(in alphabetical order)
Ronghu Wu, Georgia Institute of Technology, United States
Submitting User: xusenhan
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.